| 臺大學術典藏 |
2020-08-12T07:47:01Z |
The importance of tracheostomy to the weaning success in patients with conscious disturbance in the respiratory care center
|
Lee Y.-C.; Kuo C.-D.; Hsu H.-S.; Wu H.-D.; Hsu C.-L.; HAO-CHIEN WANG |
| 臺大學術典藏 |
2020-08-12T07:46:59Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Yu C.-J.; Keng L.-T.;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Hao-Chien Wang;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; HAO-CHIEN WANG; Kuo P.-H.; Wu H.-D.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:35:54Z |
Timing of tracheostomy as a determinant of weaning success in critically ill patients: a retrospective study.
|
CHONG-JEN YU; Yang P.C.; Jerng J.S.; Chang C.H.; Hsu C.L.;Chen K.Y.;Chang C.H.;Jerng J.S.;Chong-Jen Yu;Yang P.C.; Hsu C.L.; Chen K.Y. |
| 臺大學術典藏 |
2020-08-12T06:35:18Z |
Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns
|
Lee L.-N.; Shu C.-C. ;Lee C.-H. ;Hsu C.-L. ;Wang J.-T. ;Wang J.-Y. ;Chong-Jen Yu ;Lee L.-N.; Shu C.-C.; Lee C.-H.; Hsu C.-L.; Wang J.-T.; Wang J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:34:53Z |
Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis
|
Chung K.-P.;Chang H.-T.;Lo S.-C.;Chang L.-Y.;Lin S.-Y.;Cheng A.;Huang Y.-T.;Chen C.-C.;Lee M.-R.;Chen Y.-J.;Hou H.-H.;Hsu C.-L.;Jerng J.-S.;Ho C.-C.;Huang M.-T.;Chong-Jen Yu;Yang P.-C.; Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; Lin S.-Y.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; CHONG-JEN YU; Yang P.-C.; Cheng A.; Huang Y.-T.; Chen C.-C.; Lee M.-R.; Chen Y.-J. |
| 臺大學術典藏 |
2020-08-12T06:34:48Z |
Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study
|
Shu C.-C.;Hsu C.-L.;Lee C.-Y.;Wang J.-Y.;Wu V.-C.;Yang F.-J.;Wang J.-T.;Chong-Jen Yu;Lee L.-N.; Shu C.-C.; Hsu C.-L.; Lee C.-Y.; Wang J.-Y.; Wu V.-C.; Yang F.-J.; Wang J.-T.; CHONG-JEN YU; Lee L.-N. |
| 臺大學術典藏 |
2020-08-12T06:34:47Z |
Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission
|
Chien Y.-F.;Chen C.-Y.;Hsu C.-L.;Chen K.-Y.;Chong-Jen Yu; Chien Y.-F.; Chen C.-Y.; Hsu C.-L.; Chen K.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:34:22Z |
Increased Plasma Acetylcarnitine in Sepsis Is Associated with Multiple Organ Dysfunction and Mortality: A Multicenter Cohort Study
|
CHONG-JEN YU; Kuo C.-H.; Huang M.-T.; Hsu C.-L.; Chen Y.-J.; Liu W.-L.; Chung K.-P.; Chen G.-Y.; Chuang T.-Y.; Huang Y.-T.; Chang H.-T.; Chen Y.-F.; Chung K.-P.;Chen G.-Y.;Chuang T.-Y.;Huang Y.-T.;Chang H.-T.;Chen Y.-F.;Liu W.-L.;Chen Y.-J.;Hsu C.-L.;Huang M.-T.;Kuo C.-H.;Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:16Z |
Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis
|
Hisata S.; Cho S.J.; Nakahira K.; Imamura M.; Choi M.E.; CHONG-JEN YU; Cloonan S.M.; Choi A.M.K.; Chen Y.-J.; Chung K.-P.; Hsu C.-L.; Fan L.-C.; Huang Z.; Bhatia D.; Chung K.-P.;Hsu C.-L.;Fan L.-C.;Huang Z.;Bhatia D.;Chen Y.-J.;Hisata S.;Cho S.J.;Nakahira K.;Imamura M.;Choi M.E.;Chong-Jen Yu;Cloonan S.M.;Choi A.M.K. |
| 臺大學術典藏 |
2020-08-12T06:34:15Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:34:10Z |
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
|
Chang H.-C.;Hsu C.-L.;Chang Y.-L.;Chong-Jen Yu; Chang H.-C.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T05:14:11Z |
Effects of acute critical illnesses on the performance of interferon-gamma release assay
|
Huang C.-T.;Ruan S.-Y.;Tsai Y.-J.;Kuo P.-H.;Ku S.-C.;Lee P.-L.;Kuo L.-C.;Hsu C.-L.;Huang C.-K.;Yang C.-Y.;Ying-Chun Chien;Wang J.-Y.;Yu C.-J.; Huang C.-T.; Ruan S.-Y.; Tsai Y.-J.; Kuo P.-H.; Ku S.-C.; Lee P.-L.; Kuo L.-C.; Hsu C.-L.; Huang C.-K.; Yang C.-Y.; YING-CHUN CHIEN; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:41Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:38Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Shih J.-Y.; Hsu C.-L.; Lin C.-K.; Liao W.-Y.; CHAO-CHI HO; Yu K.-L.;Tsai T.-H.;Chao-Chi Ho;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-12T02:50:37Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Hsu C.-L.; CHAO-CHI HO; Liao W.-Y.; Chen J.-S.; Lin Y.-T.; Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Chao-Chi Ho;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-05T07:05:27Z |
Erratum: GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
|
Lin, M-C; Lin, J-J; Hsu, C-L; Juan, H-F; Lou, P-J; MIN-CHUAN HUANG |
| 臺大學術典藏 |
2020-07-21T06:46:31Z |
Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors
|
Hsu C.-L.; Chen K.-Y.; Shih J.-Y.; CHAO-CHI HO; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:27Z |
Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis
|
Huang Y.-T.; Chen C.-C.; Lee M.-R.; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; CHAO-CHI HO; Huang M.-T.; Yu C.-J.; Yang P.-C.; Lin S.-Y.; Cheng A.; Chang L.-Y.; Lo S.-C.; Chang H.-T.; Chung K.-P. |
| 臺大學術典藏 |
2020-07-21T06:46:21Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; Tsai T.-H.; Chen K.-Y.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Yu C.-J.; Yang J.C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Hsu C.-L.; Lin C.-K.; Liao W.-Y.; Yu K.-L.; Tsai T.-H.; CHAO-CHI HO; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:16Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; CHAO-CHI HO; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
